Medicare Enrolled

Dr. Mahyar Ajir, D.O.

Family Medicine · Carlsbad, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2801 JEFFERSON ST, Carlsbad, CA 92008
7607294952
In practice since 2006 (19 years)
NPI: 1518999218 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ajir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ajir? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ajir

Dr. Mahyar Ajir is a family medicine specialist in Carlsbad, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ajir performed 765 Medicare services across 692 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ajir received a total of $8,132 from 47 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ajir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in CA $8,132 industry payments

Medicare Practice Summary

Medicare Utilization ↗
765
Medicare services
Top 29% in CA for family medicine
692
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~40 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
189 $69 $112
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
115 $139 $159
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
94 $30 $30
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
92 $72 $76
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
55 $95 $149
Annual depression screening 55 $20 $26
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
35 $43 $75
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
31 $275 $290
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
31 $30 $30
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $134 $189
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
19 $107 $145
Prostate cancer screening; digital rectal examination
A physical exam where a healthcare provider inserts a gloved, lubricated finger into the rectum to check the prostate gland for abnormalities.
15 $14 $28
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
14 $77 $110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,132
Total received (2018-2024)
Avg $1,162/year across 7 years
Top 5% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,132 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,440
2023
$1,196
2022
$1,604
2021
$944
2020
$826
2019
$801
2018
$1,321

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$612
GlaxoSmithKline, LLC.
$207
Edwards Lifesciences Corporation
$172
Eisai Inc.
$124
ABBVIE INC.
$90
Otsuka America Pharmaceutical, Inc.
$52
Seqirus USA Inc
$48
Bayer Healthcare Pharmaceuticals Inc.
$34
Dexcom, Inc.
$28
Boston Scientific Corporation
$21
IRONWOOD PHARMACEUTICALS, INC
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
PFIZER INC.
$16
Top 3 companies account for 68.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,876
GlaxoSmithKline, LLC.
$1,353
SANOFI-AVENTIS U.S. LLC
$473
Lilly USA, LLC
$411
Amgen Inc.
$378
PFIZER INC.
$326
Merck Sharp & Dohme Corporation
$287
ABBVIE INC.
$263
Bayer HealthCare Pharmaceuticals Inc.
$251
Boehringer Ingelheim Pharmaceuticals, Inc.
$229
Edwards Lifesciences Corporation
$217
Eisai Inc.
$195
Novo Nordisk Inc
$171
SANOFI PASTEUR INC.
$155
AMAG Pharmaceuticals, Inc.
$140
Amarin Pharma Inc.
$139
Janssen Pharmaceuticals, Inc
$133
AbbVie, Inc.
$120
Seqirus USA Inc
$98
Abbott Laboratories
$86
Vanda Pharmaceuticals Inc.
$70
AbbVie Inc.
$67
Exact Sciences Corporation
$65
Takeda Pharmaceuticals U.S.A., Inc.
$53
Otsuka America Pharmaceutical, Inc.
$52
Merck Sharp & Dohme LLC
$52
TOPCON HEALTHCARE SOLUTIONS, INC.
$41
Bayer Healthcare Pharmaceuticals Inc.
$34
IDORSIA PHARMACEUTICALS US INC
$30
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$29
Actelion Pharmaceuticals US, Inc.
$28
Dexcom, Inc.
$28
Medtronic, Inc.
$22
DEXCOM, INC.
$22
Allergan Inc.
$22
Boston Scientific Corporation
$21
Esperion Therapeutics, Inc.
$21
NeoTract Inc.
$21
Itamar Medical Inc
$20
Mylan Specialty L.P.
$20
Biohaven Pharmaceutical Holding Company Ltd.
$19
IRONWOOD PHARMACEUTICALS, INC
$18
Duchesnay USA Incorporated
$17
Daiichi Sankyo Inc.
$17
Allergan, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Sanofi Pasteur Inc.
$11
Top 3 companies account for 45.5% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Androgel · BELSOMRA · BEXSERO · BOTOX · BREO · BREZTRI · CHANTIX · COLOGUARD · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Flucelvax · FreeStyle Libre 2 · GARDASIL 9 · GUARDIAN CONNECT · HARMONY · HETLIOZ · INJECTAFER · INTRAROSA · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · Kerendia · LINZESS · LYRICA · Leqembi · LifeVest · Linzess · MENACTRA · MOUNJARO · NEXLETOL · NURTEC ODT · OPSUMIT · Osphena · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · Prolia · QUVIVIQ · RYBELSUS · Repatha · SAPIEN 3 Ultra RESILIA · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TRUMENBA · Trintellix · UBRELVY · UroLift · VIIBRYD · Vascepa · Victoza · WATCHMAN FLX · WatchPAT · XARELTO · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in CA.

Looking for a family medicine specialist in Carlsbad?
Compare family medicine physicians in the Carlsbad area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
702
Per 100K population
21.4
County median income
$102,285
Nearest hospital
TRI-CITY MEDICAL CENTER
4.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ajir is a clinical cardiology specialist, with above-average Medicare volume (top 29% in CA), with low-engagement industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ajir experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ajir performed 189 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ajir receive payments from pharmaceutical companies?
Yes. Dr. Ajir received a total of $8,132 from 47 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ajir's costs compare to other family medicine physicians in Carlsbad?
Dr. Ajir's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ajir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →